BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26091718)

  • 1. Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell Activation.
    Li G; Ju J; Weyand CM; Goronzy JJ
    J Immunol; 2015 Aug; 195(3):865-74. PubMed ID: 26091718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering.
    Sécca C; Faget DV; Hanschke SC; Carneiro MS; Bonamino MH; de-Araujo-Souza PS; Viola JP
    J Leukoc Biol; 2016 Nov; 100(5):1081-1091. PubMed ID: 27286791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related impairment of human T lymphocytes' activation: specific differences between CD4(+) and CD8(+) subsets.
    Schindowski K; Fröhlich L; Maurer K; Müller WE; Eckert A
    Mech Ageing Dev; 2002 Feb; 123(4):375-90. PubMed ID: 11744048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naive CD4+ T lymphocytes circulate through lymphoid organs to interact with endogenous antigens and upregulate their function.
    Tomura M; Itoh K; Kanagawa O
    J Immunol; 2010 May; 184(9):4646-53. PubMed ID: 20304829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cells from elderly persons respond to neoantigenic stimulation with an unimpaired IL-2 production and an enhanced differentiation into effector cells.
    Gomez I; Marx F; Gould EA; Grubeck-Loebenstein B
    Exp Gerontol; 2004 Apr; 39(4):597-605. PubMed ID: 15050295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog signaling modulates activation of and cytokine production by human peripheral CD4+ T cells.
    Stewart GA; Lowrey JA; Wakelin SJ; Fitch PM; Lindey S; Dallman MJ; Lamb JR; Howie SE
    J Immunol; 2002 Nov; 169(10):5451-7. PubMed ID: 12421920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.
    Arimoto-Miyamoto K; Kadowaki N; Kitawaki T; Iwata S; Morimoto C; Uchiyama T
    Immunology; 2010 May; 130(1):137-49. PubMed ID: 20201989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation.
    Fornara O; Odeberg J; Khan Z; Stragliotto G; Peredo I; Butler L; Söderberg-Nauclér C
    Immunobiology; 2013 Aug; 218(8):1034-40. PubMed ID: 23434301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4⁺CD28null T lymphocytes resemble CD8⁺CD28null T lymphocytes in their responses to IL-15 and IL-21 in HIV-infected patients.
    Echeverría A; Moro-García MA; Asensi V; Cartón JA; López-Larrea C; Alonso-Arias R
    J Leukoc Biol; 2015 Sep; 98(3):373-84. PubMed ID: 26034206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
    Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
    Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity.
    Urban SL; Berg LJ; Welsh RM
    Virology; 2016 Jun; 493():52-9. PubMed ID: 26999026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells.
    Wu CY; Demeure C; Kiniwa M; Gately M; Delespesse G
    J Immunol; 1993 Aug; 151(4):1938-49. PubMed ID: 8102154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artesunate inhibits proliferation of naïve CD4(+) T cells but enhances function of effector T cells.
    Lee SH; Cho YC; Kim KH; Lee IS; Choi HJ; Kang BY
    Arch Pharm Res; 2015 Jun; 38(6):1195-203. PubMed ID: 25370606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T cells upregulate CD69 after coculture with xenogeneic genetically-modified pig mesenchymal stromal cells.
    Li J; Andreyev O; Chen M; Marco M; Iwase H; Long C; Ayares D; Shen Z; Cooper DK; Ezzelarab MB
    Cell Immunol; 2013; 285(1-2):23-30. PubMed ID: 24044963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
    Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
    Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of T-Cell activation by CXCL12/stromal cell derived factor-1 involves a G-protein mediated signaling pathway.
    Nanki T; Lipsky PE
    Cell Immunol; 2001 Dec; 214(2):145-54. PubMed ID: 12088413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines.
    Croft M; Swain SL
    J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.